An apolipoprotein A-I mimetic peptide designed with a reductionist approach stimulates reverse cholesterol transport and reduces atherosclerosis in mice (Q34851167)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	An apolipoprotein A-I mimetic peptide designed with a reductionist approach stimulates reverse cholesterol transport and reduces atherosclerosis in mice	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

An apolipoprotein A-I mimetic peptide designed with a reductionist approach stimulates reverse cholesterol transport and reduces atherosclerosis in mice (English)

1 reference

Europe PubMed Central

4 August 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

Alan T. Remaley

6

object named as

Alan Remaley

1 reference

Europe PubMed Central

4 August 2017

author name string

Michael Ditiatkovski

1

1 reference

Europe PubMed Central

4 August 2017

Wilissa D'Souza

2

1 reference

Europe PubMed Central

4 August 2017

Rajitha Kesani

3

1 reference

Europe PubMed Central

4 August 2017

Jaye Chin-Dusting

4

1 reference

Europe PubMed Central

4 August 2017

Judy B de Haan

5

1 reference

Europe PubMed Central

4 August 2017

Dmitri Sviridov

7

1 reference

Europe PubMed Central

4 August 2017

language of work or name

0 references

publication date

9 July 2013

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

8

1 reference

Europe PubMed Central

4 August 2017

7

1 reference

Europe PubMed Central

4 August 2017

e68802

1 reference

Europe PubMed Central

4 August 2017

copyright license

Creative Commons CC0 License

9 July 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

A novel approach to oral apoA-I mimetic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

Cholesterol efflux assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

Sidedness of interfacial arginine residues and anti-atherogenicity of apolipoprotein A-I mimetic peptides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

A new recombinant human apolipoprotein E mimetic peptide with high-density lipoprotein binding and function enhancing activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

Helix stabilization of amphipathic peptides by hydrocarbon stapling increases cholesterol efflux by the ABCA1 transporter

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

HDL therapy: two kinds of right?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

The effect of HDL mimetic peptide 4F on PON1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

Enhancing apolipoprotein A-I-dependent cholesterol efflux elevates cholesterol export from macrophages in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

Apolipoprotein AI mimetic peptides: possible new agents for the treatment of atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

Binding of amphiphilic peptides to phospholipid/cholesterol unilamellar vesicles: a model for protein--cholesterol interaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

8 July 2018

Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068802

21 January 2018

Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068802

21 January 2018

Antiatherogenic effects of newly developed apolipoprotein A-I mimetic peptide/phospholipid complexes against aortic plaque burden in Watanabe-heritable hyperlipidemic rabbits.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068802

21 January 2018

Elevated HDL cholesterol is functionally ineffective in cardiac transplant recipients: evidence for impaired reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068802

21 January 2018

Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068802

21 January 2018

High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068802

21 January 2018

Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068802

21 January 2018

Reverse D4F, an apolipoprotein-AI mimetic peptide, inhibits atherosclerosis in ApoE-null mice

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068802

21 January 2018

ApoA-I mimetic peptides with differing ability to inhibit atherosclerosis also exhibit differences in their interactions with membrane bilayers.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068802

21 January 2018

ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0068802

21 January 2018

A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3706315

26 October 2018

Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol

1 reference

https://pubmed.ncbi.nlm.nih.gov/23874769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective labeling of α- or ϵ-amino groups in peptides by the Bolton-Hunter reagent

1 reference

https://pubmed.ncbi.nlm.nih.gov/23874769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0068802

1 reference

Europe PubMed Central

4 August 2017

2013PLoSO...868802D

0 references

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34851167&oldid=2107717984"